A PHASE-I TRIAL OF 3-HOUR INFUSIONS OF PACLITAXEL (TAXOL) WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR

被引：0
|
作者：
SCHILLER, JH [1 ]
STORER, B [1 ]
TUTSCH, K [1 ]
ARZOOMANIAN, R [1 ]
ALBERTI, D [1 ]
FEIERABEND, C [1 ]
SPRIGGS, D [1 ]
机构：
[1] UNIV WISCONSIN,CTR COMPREHENS CANC,MADISON,WI
来源：
SEMINARS IN ONCOLOGY | 1994年 / 21卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9 / 14
页数：6
相关论文
共 50 条
  • [1] PHASE-I TRIAL OF 3-HOUR INFUSION OF PACLITAXEL WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED CANCER
    SCHILLER, JH
    STORER, B
    TUTSCH, K
    ARZOOMANIAN, R
    ALBERTI, D
    FEIERABEND, C
    SPRIGGS, D
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) : 241 - 248
  • [2] PHARMACOKINETICS OF PIROXANTRONE IN A PHASE-I TRIAL OF PIROXANTRONE AND GRANULOCYTE-COLONY-STIMULATING FACTOR
    BERG, SL
    SAVARESE, DMF
    BALIS, FM
    DENICOFF, AM
    HILLIG, M
    OSHAUGHNESSY, JA
    POPLACK, DG
    COWAN, KH
    CANCER RESEARCH, 1993, 53 (11) : 2587 - 2590
  • [3] Tolerance of paclitaxel 3-hour infusion with and without granulocyte colony-stimulating factor on a biweekly schedule
    Garcia, AA
    Parimoo, D
    Dimery, I
    Rogers, M
    Jeffers, S
    Muggia, FM
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S62 - S66
  • [4] Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma
    Ibrahim, NK
    Buzdar, AU
    Valero, V
    Dhingra, K
    Willey, J
    Hortobagyi, GN
    CANCER, 2001, 91 (04) : 664 - 671
  • [5] PHASE-I TRIAL OF TAXOL GIVEN AS A 3-HOUR INFUSION EVERY 3 WEEKS
    OCONNELL, JP
    KRIS, MG
    GRALLA, RJ
    WERTHEIM, MS
    YOUNG, CW
    SYKES, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 169 - 169
  • [6] PHASE-I STUDY OF ACCELERATED FEC WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (LENOGRASTIM) SUPPORT
    BISSETT, D
    JODRELL, D
    HARNETT, AN
    HABESHAW, T
    KAYE, SB
    EVANS, D
    WILLIAMS, M
    CANNEY, PA
    BRITISH JOURNAL OF CANCER, 1995, 71 (06) : 1279 - 1282
  • [7] PHASE-I STUDY OF HIGH-DOSE PIROXANTRONE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR
    SAVARESE, DMF
    DENICOFF, AM
    BERG, SL
    HILLIG, M
    BAKER, SP
    OSHAUGHNESSY, JA
    CHOW, C
    OTTERSON, GA
    BALIS, FM
    POPLACK, DG
    COWAN, KH
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) : 1795 - 1803
  • [8] PHASE-I AND PHARMACOLOGICAL STUDY OF PACLITAXEL AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR - NEUROMUSCULAR TOXICITY IS DOSE-LIMITING
    ROWINSKY, EK
    CHAUDHRY, V
    FORASTIERE, AA
    SARTORIUS, SE
    ETTINGER, DS
    GROCHOW, LB
    LUBEJKO, BG
    CORNBLATH, DR
    DONEHOWER, RC
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 2010 - 2020
  • [9] PHASE-I TRIAL OF TAXOL GIVEN AS A 3-HOUR INFUSION EVERY 21 DAYS
    KRIS, MG
    OCONNELL, JP
    GRALLA, RJ
    WERTHEIM, MS
    PARENTE, RM
    SCHIFF, PB
    YOUNG, CW
    CANCER TREATMENT REPORTS, 1986, 70 (05): : 605 - 607
  • [10] A PHASE-I TRIAL OF CONCOMITANT CHEMORADIOTHERAPY WITH CISPLATIN DOSE INTENSIFICATION AND GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR ADVANCED MALIGNANCIES OF THE CHEST
    VOKES, EE
    HARAF, DJ
    DRINKARD, LC
    HOFFMAN, PC
    FERGUSON, MK
    VOGELZANG, NJ
    WATSON, S
    LANE, NJ
    GOLOMB, HM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (04) : 304 - 312
12345